Aegerion Pharmaceuticals

Last updated: 02.02.2015

aegerion-bigAegerion Pharmaceuticals is a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases. At present, Aegerion is in the process of registering lomitapide in markets worldwide, and plans to conduct clinical development activities to support a marketing authorization application for lomitapide in HoFH in Japan and in support of our planned clinical study of lomitapide in pediatric and adolescent HoFH patients.


Contact info:

Rosario Cestau

Country Manager, Argentina

Av. Libertador 2442, Suite 406 {B1636DSR} Olivos, Buenos Aires

Tel: +5411 – 4711 8228 | Mobile: +54 911 3874 7608 |


We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here